The investment will focus on developing gelatin and HPMC facilities, creating over 200 new jobs, and strengthening ACG’s 25-year presence in the US, with operations expected to begin in early 2027.
The Covid pandemic and its repercussions have changed the pharmaceutical industry and the healthcare markets. Richard Stedman, the CEO of ACG Engineering, discusses the lessons learned from the global supply chain disruptions and how innovative equipment helps pharma manufacturers overcome the challenges.
Solvay said it plans to resume construction on its 600,000 t/y soda ash capacity expansion at its Green River, Wyoming, US plant, with production now expected to start at the end of 2024. The project was put on hold in September 2020, due to the coronavirus pandemic
After establishing its first-to-market laboratory for process development in India, ACG, an integrated solutions provider for pharmaceutical companies, now plans to launch a sister process lab in Germany in 2023.
ISPE and its members are developing the roadmap to introduce Industry 4.0, also called the Smart Factory, at the pharmaceutical industry as Pharma 4.0 – an operating model that is interconnected, meaning that the digital tools allow for a fully connected network to enable direct communication between all levels in an organization.
ISPE and its members are developing the roadmap to introduce Industry 4.0, also called the Smart Factory, at the pharmaceutical industry as Pharma 4.0 – an operating model that is interconnected, meaning that the digital tools allow for a fully connected network to enable direct communication between all levels in an organization.
Marcus Michel, CEO of ACG Engineering, analyzes market trends in pharmaceutical engineering and manufacturing.
ACG has appointed Marcus Michel as the new CEO of ACG Engineering, taking over from Richard Stedman, who will remain with the company as a special advisor over the next few months to support a seamless transition.
India’s ACG, a provider of pharmaceutical packaging, engineering equipment and inspection systems, has acquired a “significant” stake in compatriot start-up Iqgen-X, a contract research organization (CRO) that delivers niche and complex drug development technologies for the pharmaceutical industry.
